Your browser doesn't support javascript.
loading
Cediranib combined with carboplatin and paclitaxel in patients with metastatic or recurrent cervical cancer (CIRCCa): a randomised, double-blind, placebo-controlled phase 2 trial.
Symonds, R Paul; Gourley, Charlie; Davidson, Susan; Carty, Karen; McCartney, Elaine; Rai, Debbie; Banerjee, Susana; Jackson, David; Lord, Rosemary; McCormack, Mary; Hudson, Emma; Reed, Nicholas; Flubacher, Maxine; Jankowska, Petra; Powell, Melanie; Dive, Caroline; West, Catharine M L; Paul, James.
Afiliación
  • Symonds RP; Department of Cancer Studies, University of Leicester, Leicester, UK. Electronic address: rps8@le.ac.uk.
  • Gourley C; University of Edinburgh Cancer Research UK Centre, MRC IGMM, Edinburgh, UK.
  • Davidson S; The Christie NHS Foundation Trust, Manchester, UK.
  • Carty K; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • McCartney E; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Rai D; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Banerjee S; Gynaecology Unit, Royal Marsden Hospital NHS Foundation Trust, London, UK.
  • Jackson D; Institute of Oncology, Leeds Cancer Centre, St James's University Hospital, Leeds UK.
  • Lord R; Clatterbridge Centre for Oncology, University of Liverpool, Liverpool, UK.
  • McCormack M; Oncology Department, University College Hospital, London, UK.
  • Hudson E; Velindre Hospital, Cardiff, UK.
  • Reed N; Beatson West of Scotland Cancer Centre, Gartnavel General Hospital, Glasgow, UK.
  • Flubacher M; Oncology Department, Poole Hospital, Dorset, UK.
  • Jankowska P; Musgrove Park Hospital, Taunton and Somerset NHS Foundation Trust, Taunton, UK.
  • Powell M; St Bartholomew's Hospital, London, UK.
  • Dive C; Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.
  • West CML; Institute of Cancer Sciences, University of Manchester, Manchester, UK.
  • Paul J; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
Lancet Oncol ; 16(15): 1515-1524, 2015 Nov.
Article en En | MEDLINE | ID: mdl-26474517
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Quinazolinas / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias del Cuello Uterino / Carboplatino / Paclitaxel / Recurrencia Local de Neoplasia / Antineoplásicos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Female / Humans / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Quinazolinas / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias del Cuello Uterino / Carboplatino / Paclitaxel / Recurrencia Local de Neoplasia / Antineoplásicos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Female / Humans / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article